Business


Futura Sets Sights On Taking Eroxon To China

 
• By 

With the grant of a patent, Futura is hoping to take its Eroxon product to China, a country with a large population of ED sufferers, the firm claims.

Venture Life Offloads Oral Care Assets To Focus on Power Brands

 
• By 

Covestus Holdings will pay £4.3m to acquire UK-based Venture Life’s oral care brands Ultradex and Dentyl.

Cooper And Dr Reddy’s Take Charge Of Nicotinell In Key European Markets

 
• By 

France, Spain and Belgium among countries where Cooper Consumer Health has launched NRT brand Nicotinell on behalf of Dr Reddy’s.

Reckitt Seizes OTC Growth Opportunity In Emerging Markets

 
• By 

Reckitt's leadership discussed the company's growth strategy for emerging markets at a recent meeting for analysts.

Innovation & IP


Futura Sets Sights On Taking Eroxon To China

 
• By 

With the grant of a patent, Futura is hoping to take its Eroxon product to China, a country with a large population of ED sufferers, the firm claims.

US Sunscreen And OTC Monograph Milestones Marked By DSM-Firmenich’s Bemotrizinol Proposal

 

FDA’s proposed order follows its review of OMOR DSM-Firmenich submitted showing bemotrizinol, at concentrations up to 6%, is generally recognized as safe and effective and can be added as an active ingredient to sunscreen monograph.

OTC Firms Must Strike Delicate Balance Between Trust And Personalization

 
• By 

“In the coming years, growth will depend on whether brands can combine trust, personalization, and proof of evidence into one coherent prevention experience,” argue Simon Kucher's Clemens Oberhammer and Christian Rebholz in this exclusive interview.

OTC Marketing Awards 2025: What The Judges Said About The Leading Entries

 
• By 

The trophies have been presented at the OTC Marketing Awards 2025 - but what did the judging panel have to say about the winning and highly-commended entries?

Policy & Regulation


Can US FDA Balance Inspection Generalists And ‘Simple Reform’ With Need For Expertise?

 
• By 

Former agency officials now representing industry worry that a deregulatory bent could be driving "Simple Reform" plan to merge all medical product and clinical research inspectorates and that specialist expertise gained in 2017 "Program Alignment" initiative will be reversed.

US Homeopathic Firm Recalling Contaminated Nasal Sprays Challenged FDA’s Regulatory Shift

 

MediNatura expands recall to include all lots of both ReBoost and ClearLife nasal sprays after microbial contamination and yeast or mold were found. Firm in 2021 challenged homeopathic drug oversight change from policy in place since 1988.

Industry Blasts Commission’s Urban Wastewater Directive Cost Review

 
• By 

Only taking inflation into account, the European Commission’s new cost estimate of between €1.48bn to €1.8bn per year, when adjusted for inflation, results in a total very similar to the original €1.2bn estimate.

Slow Burn For US Sunscreen Innovation While FDA Lights Lamp For Monograph Overhaul Deadlines

 

Sunscreen products industry and public health advocacy groups have been critical that FDA has not approved a new filter since 1999 even as countries in Europe and other regions allow using numerous additional ingredients in sunscreens.

Rx-to-OTC Switch


US OTC Switches: FDA Needs Comments To Guide Public Meeting, Congress Wants Progress Report

 

Agency intends to use information from comments to guide its planning for a public meeting during 2026, according to a Federal Register notice. A GAO report is due in a year to Congress profiling FDA’s progress on making more drugs available nonprescription through OTC switch applications.

PAGB Wants 25 Rx-To-OTC Switches Over Next Five Years In The UK

 
• By 

UK consumer healthcare industry association, PAGB, suggests improvements that could help accelerate Rx-to-OTC switch in the country.

‘Fake News’ And Chatbots Pose Threat To Italy’s Responsible Self-Medication Model

 
• By 

A new cohort of “techno-enthusiasts” who are highly susceptible to misinformation and inappropriate self-care decisions are undermining Italy's responsible self-medication model, finds a report by Italian self-care industry association, Assosalute, and independent researcher Censis.

Opella: Unlock Volume Growth By Expanding Access And Deepening Category Penetration

 
• By 

Negative growth in global OTC market sales volume means that “as an industry, we're not doing good enough,” argues Opella’s Asia Pacific, Middle East and Africa (AMEA) head, Carol-Ann Stewart, in this exclusive feature interview.